ArticleFrontiers in immunology2025

A lactylation-ferroptosis cross-talk gene signature predicts hepatocellular carcinoma prognosis and reveals STMN1/PRDX1 as therapeutic targets.

Jiali Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.